CVE-2026-15415
AWS HealthOmics is a HIPAA-eligible service that fully manages the …
AWS HealthOmics is a HIPAA-eligible service that fully manages the compute, storage, and workflow engine infrastructure required to run bioinformatics analyses at scale for clinical diagnostics, drug discovery, and agricultural research. Improper limitation of a pathname to a restricted directory in the linting tools of the AWS HealthOmics MCP Server (aws-healthomics-mcp-server) before version 0.0.36 might allow an actor who can influence the MCP agent to write an actor-controlled content to arbitrary locations outside the intended workflow bundle directory, via directory traversal sequences in the workflow_files input. To remediate this issue, users should upgrade to version 0.0.36 or later.
What to do now
- Check your exposureFind out whether the affected software runs anywhere in your environment, including systems of suppliers.
- UpdateInstall the version in which the vendor fixed the vulnerability. The references lead to the advisory.
- Set the orderSystems that can be reached from the internet come first, then the rest.
References
Data: CVE list and the NVD. This product uses data from the NVD API but is not endorsed or certified by the NVD.